← Back to Clinical Trials
Recruiting NCT06192082

NCT06192082 Adverse Cardiovascular Events During Painless Gastroscopy Diagnosis and Treatment in Elderly Frail Patients

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT06192082
Status Recruiting
Phase
Sponsor Beijing Friendship Hospital
Condition Anesthesia
Study Type INTERVENTIONAL
Enrollment 226 participants
Start Date 2024-01-01
Primary Completion 2026-02-12

Eligibility & Interventions

Sex All sexes
Min Age 65 Years
Max Age 100 Years
Study Type INTERVENTIONAL
Interventions
The conscious sedation groupIntravenous general anesthesia group

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

What to Expect as a Participant

You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.

This trial targets 226 participants in total. It began in 2024-01-01 with a primary completion date of 2026-02-12.

⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.

Brief Summary

This study aims to compare the effects of conscious sedation and intravenous general anesthesia on cardiovascular events in frail patients undergoing digestive endoscopy diagnosis and treatment.

Eligibility Criteria

Inclusion Criteria: 1. Age greater than 65 years old, regardless of gender 2. ASA is classified as Class II and III; 3. BMI 18-28 kg/m2; 4. Patients undergoing examination or treatment outside the operating room; 5. FRAIL scale score ≥ 3 points 6 The patient voluntarily participated in this study and signed an informed consent form. Exclusion Criteria: 1 Those who are allergic or contraindicated to drugs such as benzodiazepines, opioids, propofol, and their drug components; 2\. Acute heart failure; Unstable angina pectoris; Myocardial infarction occurred within 6 months prior to screening; Resting electrocardiogram heart rate\<50 beats/minute; Third degree atrioventricular transmission delay; Severe arrhythmia; Moderate to severe heart valve disease; 3\. Patients with severe respiratory diseases (acute respiratory infections, acute exacerbations of chronic obstructive pulmonary disease, uncontrolled asthma, etc.); 4\. Patients who have not received formal antihypertensive treatment or have poor blood pressure control; 5\. Patients with traumatic brain injury, possible presence of intracranial hypertension, cerebral aneurysms, history of cerebrovascular accidents, and central nervous system diseases; 6\. Individuals with mental system diseases (schizophrenia, mania, bipolar disorder, mental disorder, etc.), long-term history of taking psychotropic drugs, and cognitive impairment; 7\. Other situations that have been determined by the researcher to be unsuitable for inclusion.

Contact & Investigator

Central Contact

Haijun Hou, MD

✉ 77790690@qq.com

📞 +8618612568228

Frequently Asked Questions

Who can join the NCT06192082 clinical trial?

This trial is open to participants of all sexes, aged 65 Years or older, up to 100 Years, studying Anesthesia. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.

Is NCT06192082 currently recruiting?

Yes, NCT06192082 is actively recruiting participants. Contact the research team at 77790690@qq.com for enrollment information.

Where is the NCT06192082 trial being conducted?

This trial is being conducted at Beijing, China.

Who is sponsoring the NCT06192082 clinical trial?

NCT06192082 is sponsored by Beijing Friendship Hospital. The trial plans to enroll 226 participants.

Related Trials

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: April 2026  ·  Data Methodology